Sign up to save your podcasts
Or
Share How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain dive deep into the world of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. We are joined by Dr. John Leonard, a renowned lymphoma expert from NYU Langone Cancer Center, who shares his insights on the latest data and evolving treatment landscape for DLBCL.
Episode Highlights:
• Understanding the initial workup for DLBCL, including the role of PET-CT and bone marrow biopsies.
• The use of RCHOP and the emerging Pola-R-CHP regimen in Stage 1 and Stage 2 settings.
• Discussion on the treatment options for Stage 3 and Stage 4 disease, including the impact of polatuzumab.
• Insights into managing relapsed/refractory disease and the role of CAR-T therapy.
• The potential shift towards outpatient CAR-T treatments and the nuances between different CAR-T options.
• Exploring bispecific antibodies and their applications in treatment sequencing.
YouTube: https://youtu.be/raGkPnUs9XM
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Join us as we unpack the complexities of DLBCL treatment and share valuable clinical pearls for community settings. Don't forget to subscribe for more episodes on challenging cases and the latest in oncology!
View all episodes
By Oncology Brothers
4.8
4040 ratings
Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain dive deep into the world of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. We are joined by Dr. John Leonard, a renowned lymphoma expert from NYU Langone Cancer Center, who shares his insights on the latest data and evolving treatment landscape for DLBCL.
Episode Highlights:
• Understanding the initial workup for DLBCL, including the role of PET-CT and bone marrow biopsies.
• The use of RCHOP and the emerging Pola-R-CHP regimen in Stage 1 and Stage 2 settings.
• Discussion on the treatment options for Stage 3 and Stage 4 disease, including the impact of polatuzumab.
• Insights into managing relapsed/refractory disease and the role of CAR-T therapy.
• The potential shift towards outpatient CAR-T treatments and the nuances between different CAR-T options.
• Exploring bispecific antibodies and their applications in treatment sequencing.
YouTube: https://youtu.be/raGkPnUs9XM
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Join us as we unpack the complexities of DLBCL treatment and share valuable clinical pearls for community settings. Don't forget to subscribe for more episodes on challenging cases and the latest in oncology!
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
323 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Research To Practice | Oncology Videos
121 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
294 Listeners
White Coat Investor Podcast
2,439 Listeners
The Curbsiders Internal Medicine Podcast
3,361 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
The ONS Podcast
205 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
22 Listeners
Becker’s Healthcare Podcast
192 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Two Onc Docs
193 Listeners